Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Plasma cell 1 Gastrointestinal 1

Conditions

Anal Cancer Metastatic 1

Interventions

Oxaliplatin 95 Fluorouracil 84 Capecitabine 75 Gemcitabine 72 Leucovorin 68 Nivolumab 67 Bevacizumab 63 pembrolizumab 60 Magnetic Resonance Spectroscopy 52 Specimen Handling 50 Irinotecan 50 durvalumab 46 Radiotherapy 42 atezolizumab 40 Cisplatin 39 Paclitaxel 37 Biopsy 37 130-nm albumin-bound paclitaxel 34 Cetuximab 30 Carboplatin 27 Albumin-Bound Paclitaxel 26 Taxes 24 Drug Therapy 20 dehydroftorafur 19 Radiation 19 Ipilimumab 19 tislelizumab 18 Surgical Procedures, Operative 17 Standard of Care 17 Docetaxel 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × reolysin × Gastrointestinal × Clear all

NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡